Alva Review-Courier -

Articles written by Linda A. Johnson

Sorted by date  Results 1 - 25 of 59



FDA OKs powerful opioid pill as alternative to IV painkiller

TRENTON, N.J. (AP) — U.S. regulators on Friday approved a fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. The decision by the Food and Drug Administration came over objections from critics who fear...

 

US approves first new type of flu drug in 2 decades

TRENTON, N.J. (AP) — U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season. Xofluza is a pill that can...

 

Rising drug prices widen gap between have, have-not patients

TRENTON, N.J. (AP) — For Bridgett Snelten, changing her health insurance meant enduring wild blood sugar swings, bouts of vomiting and weight gain. The Sandy, Utah mother of two young girls has diabetes and has had to change health insurance plans...

 

Drugmakers to disclose prices for medicines advertised on TV

TRENTON, N.J. (AP) — Drugmakers will start disclosing the prices for U.S. prescription drugs that are advertised on TV, but the Trump administration said the move announced Monday doesn't go far enough. The prices won't actually be shown in the TV...

 

FDA expands use of cervical cancer vaccine up to age 45

U.S. regulators Friday expanded the use of Merck's cervical cancer vaccine to adults up to age 45. The vaccine was previously only for preteens and young adults through 26. The Food and Drug Administration approved Gardasil 9 for women and men...

 

FDA approves new pill to reduce pain from endometriosis

TRENTON, N.J. (AP) — A new treatment for pain caused by endometriosis was approved Tuesday by U.S. regulators. The common condition involves abnormal tissue growth from the uterus that can cause severe pain and infertility. Drugmaker Abbvie said...

 

FDA plans to ease OTC approvals for some prescription drugs

U.S. regulators proposed new guidelines Tuesday to make it easier for some common medicines to be sold without a prescription — and more convenient for consumers to get them. The Food and Drug Administration is evaluating ways to make sure...

 

FDA to more aggressively tackle disruptive drug shortages

The U.S. Food and Drug Administration said Thursday it wants to more aggressively fight medication shortages that have led to rationing of some drugs and disrupted patient care. The agency announced plans for a task force to find ways to improve the...

 

FDA OKs 1st drug to treat smallpox, in case of terror attack

U.S. regulators Friday approved the first treatment for smallpox — a deadly disease that was wiped out four decades ago — in case the virus is used in a terror attack. Smallpox, which is highly contagious, was eradicated worldwide by 1980 after...

 

US approves 1st drug developed to prevent chronic migraines

TRENTON, N.J. (AP) — U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration's action clears the monthly shot Aimovig (AIM'-oh-vig) for sale. It's the first in a new class of...

 

FDA names drugmakers accused of blocking cheaper generics

TRENTON, N.J. (AP) — U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions. The Food and Drug Administration's new webpage names the...

 

FDA approves 1st nonopioid drug to ease withdrawal symptoms

TRENTON, N.J. (AP) — Federal regulators on Wednesday approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids. The U.S. Food and Drug Administration expedited approval of Lucemyra to help combat the U.S. opioid...

 

New data: Americans filling far fewer opioid prescriptions

TRENTON, N.J. (AP) — The number of prescriptions for opioid painkillers filled in the U.S. fell dramatically last year, showing their biggest drop in 25 years and continuing a decline amid increasing legal restrictions and public awareness of the d...

 

Insulin quality questions have diabetes experts scrambling

TRENTON, N.J. (AP) — Preliminary research suggesting that some diabetes patients may be injecting medicine that has partially disintegrated is causing concern even as serious questions are raised about the research itself. The study author, a pharm...

 

Johnson & Johnson loses $10.7B after sweeping US tax changes

Johnson & Johnson posted a rare quarterly loss, a whopping $10.71 billion, due to a $13.6 billion charge related to last month's U.S. tax overhaul. While the loss was expected and the company's adjusted results beat Wall Street expectations, shares...

 

Hospital groups creating company to make cheap generic drugs

TRENTON, N.J. (AP) — Several major not-for-profit hospital groups are trying their own solution to drug shortages and high prices: creating a company to make cheaper generic drugs. The plan, announced Thursday, follows years of shortages of...

 

US OKs 1st drug aimed at women with inherited breast cancer

U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene...

 

Viagra goes generic: Pfizer to launch own little white pill

TRENTON, N.J. (AP) — The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first...

 

FDA approves diabetes drug that also helps with weight loss

TRENTON, N.J. (AP) — U.S. regulators on Tuesday approved a new diabetes drug that reduces blood sugar levels and also helps people lose significant weight. Danish drugmaker Novo Nordisk said the Food and Drug Administration approved its...

 

AstraZeneca wins US approval for lymphoma drug

U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma. The Food and Drug Administration on Tuesday granted accelerated approval to AstraZeneca PLC's Calquence for people with mantle cell lymphoma after...

 

FDA rejects muscular dystrophy drug, says it doesn't work

TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has rejected an experimental drug for a common type of muscular dystrophy. The FDA's decision Wednesday was expected because the agency had said the drug didn't work in two key patient test...

 

FDA OKs 2nd gene therapy for blood cancer; 1st for adults

TRENTON, N.J. (AP) — U.S. regulators have approved a second gene therapy for blood cancer. The one-time treatment is for aggressive lymphoma in adults. The Food and Drug Administration approved sales of the therapy from Kite Pharma on Wednesday....

 

FDA approves Lilly pill for common advanced breast cancer

U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body. Eli Lilly's Verzenio was approved Thursday by the Food and Drug Administration for women and men with what's...

 

FDA OKs continuous blood sugar monitor without finger pricks

U.S. regulators have approved the first continuous blood sugar monitor for diabetics that doesn't need backup finger prick tests. Current models require users to test a drop of blood twice daily to calibrate, or adjust, the monitor. The pain of...

 

FDA OKs Pfizer drug for rare, fast-killing type of leukemia

TRENTON, N.J. (AP) — The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. The agency approved Pfizer Inc.'s Besponsa for patients with a type of...

 

Page Down

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2018